Rapid advances in next-generation sequencing technologies, along with market forces, are driving a nationwide surge in demand for genomic cancer risk assessment services. Clinicians must be adequately prepared with the knowledge and skills needed to address the complexities that come with integrating genomic cancer risk assessment into practice.
Each year, City of Hope and the University of Chicago cosponsor the Clinical Cancer Genomics Conference.
This two-day gathering brings a roster of nationally recognized speakers together with community-based clinicians from across the U.S. and around the world. Presentations explore the promise and challenge of incorporating next-generation sequencing technologies into the landscape of personalized cancer risk assessment, treatment and preventive care.
The ninth annual Clinical Cancer Genomics Conference will take place April 2020, on campus at City of Hope.